Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : IBUTILIDE FUMARATE
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Approved FDF
Sponsor : Premier
Deal Size : Undisclosed
Deal Type : Partnership
Premier ProvideGx Program Partners with Pfizer
Details : Premier’s ProvideGx program identifies safe, high-quality supply sources for drugs that are or may be at risk of being added to the national drug shortage list.
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Undisclosed
February 19, 2020
Lead Product(s) : IBUTILIDE FUMARATE
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Approved FDF
Sponsor : Premier
Deal Size : Undisclosed
Deal Type : Partnership
Lead Product(s) : IBUTILIDE FUMARATE
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Undisclosed
Sponsor : Medtronic Plc
Deal Size : Inapplicable
Deal Type : Inapplicable
ECGi Ibutilide: Effect of Ibutilide on AF Source Location and Organization
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
December 12, 2017
Lead Product(s) : IBUTILIDE FUMARATE
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Undisclosed
Sponsor : Medtronic Plc
Deal Size : Inapplicable
Deal Type : Inapplicable